A Study to Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia Patients
Clinical trial NCT03855696 · COMPLETED
Trial details
- NCT number
- NCT03855696
- Sponsor
- Green Cross Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-21
- Primary completion
- 2021-06-30
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.